Pharmacokinetics of Naratriptan in Adolescent Subjects with a History of Migraine
Authors:
- 1 February 2001
- journal article
- clinical trial
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 41 (2) , 170-175
Abstract
Naratriptan is a novel 5‐HT1 agonist developed to treat acute migraine. The study objective was to characterize the pharmacokinetics of oral naratriptan in adolescent migraine patients outside a migraine attack. Subjects received a single 2.5 mg naratriptan tablet. Serial serum samples for naratriptan concentrations were collected over 24 hours. Blood pressure, pulse rate, and 12‐lead ECG were recorded at baseline and at regular intervals after dosing. Seven patients—3 males and 4 females, 12 to 16 years of age—received drug and completed the study. The geometric mean and 95% confidence interval maximum concentration (Cmax) was 8.0 ng/mL (5.9–10.7), elimination half‐life (t1/2) was 4.9 hours (4.5‐5.4), area under the concentration‐time curve (AUC) was 74.6 ng•h/mL (56.6–98.2), and apparent total clearance (Cl/F) was 558.8 mL/min (424.3–735.9). The median time to maximal concentration (tmax) was 4 hours, with a range of 1.5 to 4. Blood pressure, pulse rate, and ECG parameters did not change significantly from baseline. No serious adverse events or subject withdrawal after drug administration occurred. Oral naratriptan pharmacokinetic parameters in adolescents were similar to values reported in adults. Naratriptan doses for adolescents older than 12 years of age would be expected to be similar to adult doses.Keywords
This publication has 18 references indexed in Scilit:
- Tolerability and Efficacy of Naratriptan Tablets with Long-Term Treatment (6 Months)Cephalalgia, 1998
- SumatriptanDrugs, 1998
- The interaction between propranolol and the novel antimigraine agent zolmitriptan (311C90)British Journal of Clinical Pharmacology, 1997
- Naratriptan is Effective and Well Tolerated in the Acute Treatment of Migraine. Results of a Double‐Blind, Placebo‐Controlled, Parallel‐Group StudyHeadache: The Journal of Head and Face Pain, 1997
- 2-21-15 Efficacy and safety of naratriptan tablets in adolescent migraineJournal of the Neurological Sciences, 1997
- NaratriptanCephalalgia, 1997
- Classification of Pediatric Migraine: Proposed Revisions to the IHS CriteriaHeadache: The Journal of Head and Face Pain, 1995
- Evaluation of a Multiple-Dose Regimen of Oral Sumatriptan for the Acute Treatment of MigraineEuropean Neurology, 1991
- The Clinical Pharmacology, Pharmacokinetics and Metabolism of SumatriptanEuropean Neurology, 1991
- The migraine syndrome in children and adolescentsPediatric Neurology, 1986